Intelligence Platform
Patents
Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6200597
Formulation and use of carotenoids in treatment of cancer
expired patentUS 6200558
Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorpor
expired patentUS 6197811
Cytokine production inhibitors
expired patentUS 6197754
Suppression of tumor growth by a mini-E1A gene
expired patentUS 6197751
Thymosin .alpha.1 promotes tissue repair, angiogenesis and cell migration
expired patentUS 6197578
Cells expressing both human CD4 and a human fusion accessory factor associated with HIV in
expired patentUS 6197350
Method of producing a sustained-release preparation
expired patentUS 6197528
Composition of immunotoxins and retinoids and use thereof
expired patentUS 6197307
Method for producing high activity extracts from harpagophytum procumbens
expired patentUS 6197926
Methods for treatment of diabetes using peptide analogues of insulin
expired patentUS 6194419
Nitrogen-containing heterocyclic compounds, their production and use
expired patentUS 6194176
Recombinant expression of proteins from secretory cell lines
expired patentUS 6194460
Composition for treating cough induced by angiotensin converting enzyme inhibitors
expired patentUS 6194450
Polyaromatic heterocyclic compounds and pharmaceutical compositions comprised thereof
expired patentUS 6194390
Procedure to block the replication of reverse transcriptase dependent viruses by the use o
expired patentUS 6193949
Method of sire selection using naloxone challenge tests and kits thereof
expired patentUS 6191191
Polymerizable dental composition
expired patentUS 6190894
Method and compositions for disrupting the epithelial barrier function
expired patentUS 6190859
Method and kit for detection of dengue virus
expired patentUS 6190723
Neutralization of food allergens by thioredoxin
expired patentUS 6191269
Selective induction of cell death by delivery of amino-terminal interleukin-1-.alpha. pro-
expired patentUS 6190700
Production of sustained-release preparation for injection
expired patentUS 6190695
Pharmaceutical composition containing osteogenesis-promoting substance
expired patentUS 6190666
DNA expression systems based on alphaviruses
expired